title: [Tours experience of endovascular treatment in superior vena cava syndrome].
abstract: Superior vena cava syndrome is a clinical entity including symptoms arising from an obstruction of return flow in the superior vena cava. It can be life threatening. In the context of lung cancer, by far the most prominent etiology (nine of ten cases in our series), the condition is particularly serious, with only 20% survival at one year. Medical treatment may be insufficient, requiring surgical salvage. Palliative procedures are rapidly effective and well tolerated. We perform a first intention transluminal angioplasty under local anesthesia via the right femoral vein. This ultrasound-guided procedure enables insertion of a non-coated nitinol stent. The success rate in our hands has been 90%. Clinical improvement is constant and immediate with long-term efficacy. The early and late post-operative period is uneventful.
authors.affiliation: Service de chirurgie vasculaire, CHU Trousseau, 37044 Tours cedex 9, France. matthieu.arsicot@gmail.com
authors.forename: M
authors.initials: M
authors.lastname: Arsicot
authors.forename: H
authors.initials: H
authors.lastname: Lathelize
authors.forename: E
authors.initials: E
authors.lastname: Marchand
authors.forename: R
authors.initials: R
authors.lastname: Martinez
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D057510:Endovascular Procedures; D005260:Female; D005602:France; D006801:Humans; D008297:Male; D008875:Middle Aged; D013479:Superior Vena Cava Syndrome / Q000601:surgery*